Dr. Barbara Mccoard, M.D Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 265 Watertrough Rd, Sebastopol, CA 95472 Phone: 707-829-2565 Fax: 707-829-1783 |
Guy R Gullion, M. D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 120 Pleasant Hill Ave N, Suite 340, Sebastopol, CA 95472 Phone: 707-329-6943 |
Randy Michener Rischette, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 103 Morris Street, Suite G, Sebastopol, CA 95472 Phone: 707-524-4431 |
Dr. German Federico Ascani, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1020 Gravenstein Hwy S Ste 120, Sebastopol, CA 95472 Phone: 707-861-9208 |
David Charles Beck, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 9707 Ross Station Rd, Sebastopol, CA 95472 Phone: 707-887-2315 Fax: 707-887-2315 |
Dr. Richard Jay Hersh, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 11793 Green Valley Rd, Sebastopol, CA 95472 Phone: 707-829-9159 |
Allan L. Bernstein, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 652 Petaluma Ave, Suite H, Sebastopol, CA 95472 Phone: 707-823-7616 Fax: 707-823-2803 |
News Archive
Emergency medical service (EMS) providers in the United States assess an estimated 350,000 cardiac arrests each year. Only 5 to 10 percent of people who have sudden cardiac arrest survive. Better quality cardiopulmonary resuscitation (CPR) provided by prehospital EMS providers may be associated with better patient outcome. The Resuscitation Outcomes Consortium (ROC) is the largest clinical research network to study prehospital treatments for cardiac arrest in the United States and Canada.
Inter Press Service examines how legislation in Kenya targeting counterfeit medications and a possible EU-India Free Trade Agreement could scale back access to affordable and safe generic medications widely used in developing countries.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.
A recent study conducted by the researchers Gabrhel J., Popracová Z., Tauchmannová H. and M. Nemšák on the application of Hilterapia®, produced by ASAlaser - a company for over 30 years at the forefront of the study and development of therapeutic laser solutions - in Achilles tendinopathy and in serious tendons and ligaments disorders has confirmed its full effect.
› Verified 8 days ago